Table 3.
Model building table for nicorandil pharmacodynamics and disease progress
| Model | Disease progress | Drug effect | Random effects | Estimation | Obj | Sig |
|---|---|---|---|---|---|---|
| 10 | Exponential | Emax | Covariance of S0, SS, EC50 | Simultaneous | 7600.48 | 5.9 |
| 11 | Exponential | Emax | Covariance of S0, SS, EC50 | Sequential | 7601.34 | 6.5 |
| 12 | Exponential | Linear | Covariance of S0, SS, EC50 | Sequential | 7624.16 | 5.4 |
| 13 | Exponential | Emax | No covariance | Sequential | 7624.92 | 5.9 |
| 14 | Linear | Sigmoid Emax | Covariance of S0, alpha, Emax, EC50 | Sequential | 7634.66 | 6.6 |
| 15 | Linear | Emax | Covariance of S0, alpha, Emax, EC50 | Sequential | 7634.80 | 6.3 |
| 16 | Linear | Emax | No covariance | Sequential | 7639.33 | 5.9 |
| 17 | None | Emax | Covariance of S0, Emax, EC50 | Sequential | 7664.96 | . |
Obj, NONMEM objective function value; Sig, NONMEM estimate of minimum number of significant digits in the parameter estimates.